Phio Pharmaceuticals Corp. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$4.59 | -$4.59 | -$4.59 |
| Q2 2024 | 1 | -$4.14 | -$4.14 | -$4.14 |
| Q3 2024 | 1 | -$3.60 | -$3.60 | -$3.60 |
Phio Pharmaceuticals Corp. Earnings Date And Information
Phio Pharmaceuticals Corp. last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-3.62 earnings per share for the quarter, topping analysts' consensus estimates of $-4.59 by $0.97. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Phio Pharmaceuticals Corp. has generated $-47 earnings per share over the last year ($-46.76 diluted earnings per share) and currently has a price-to-earnings ratio of -0.34. Phio Pharmaceuticals Corp. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based on prior year's report dates.
Phio Pharmaceuticals Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$1.54 | $0 | $0 | ||
| 08/14/2024 | Q2 2024 | -$4.59 | -$3.62 | 0.97 | $0 | $0 |
| 05/09/2024 | Q1 2024 | -$4.24 | $0 | |||
| 04/01/2024 | Q4 2023 | -$4.56 | $30,000 | |||
| 11/09/2023 | Q3 2023 | -$12.87 | -$10.26 | 2.61 | $0 | |
| 08/10/2023 | Q2 2023 | -$13.29 | $0 | |||
| 05/11/2023 | Q1 2023 | -$28.41 | $0 | |||
| 03/22/2023 | Q4 2022 | -$3.24 | -$20.52 | -17.28 | $0 | |
| 11/10/2022 | Q3 2022 | $38.90 | -$28.33 | -67.23 | $12.50 M | $0 |
| 08/11/2022 | Q2 2022 | -$33.50 | -$20.11 | 13.39 | $0 | |
| 05/12/2022 | Q1 2022 | -$32.42 | -$21.07 | 11.35 | $0 | |
| 03/22/2022 | Q4 2021 | -$34.58 | -$27.57 | 7.01 | $0 | |
| 11/10/2021 | Q3 2021 | -$27.01 | -$29.89 | -2.88 | $0 | |
| 08/12/2021 | Q2 2021 | -$28.09 | -$21.46 | 6.63 | $0 | |
| 05/13/2021 | Q1 2021 | -$34.49 | $0 | |||
| 03/25/2021 | Q4 2020 | -$45.38 | -$46.05 | -0.67 | $0 | |
| 11/10/2020 | Q3 2020 | -$41.06 | -$43.18 | -2.12 | $0 | |
| 08/12/2020 | Q2 2020 | -$70.24 | -$36.40 | 33.84 | $0 | |
| 05/12/2020 | Q1 2020 | -$93.67 | $0 | |||
| 03/26/2020 | Q4 2019 | -$507.38 | $0 |
Phio Pharmaceuticals Corp. Earnings: Frequently Asked Questions
-
When is Phio Pharmaceuticals Corp.'s earnings date?
Phio Pharmaceuticals Corp. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates.
-
Did Phio Pharmaceuticals Corp. beat their earnings estimates last quarter?
In the previous quarter, Phio Pharmaceuticals Corp. (:PHIO) reported $-3.62 earnings per share (EPS) to beat the analysts' consensus estimate of $-4.59 by $0.97.
-
How can I listen to Phio Pharmaceuticals Corp.'s earnings conference call?
The conference call for Phio Pharmaceuticals Corp.'s latest earnings report can be listened to online.
-
How can I read Phio Pharmaceuticals Corp.'s conference call transcript?
The conference call transcript for Phio Pharmaceuticals Corp.'s latest earnings report can be read online.
-
How much profit does Phio Pharmaceuticals Corp. generate each year?
Phio Pharmaceuticals Corp. (:PHIO) has a recorded net income of $0. Phio Pharmaceuticals Corp. has generated $-46.87 earnings per share over the last four quarters.
-
What is Phio Pharmaceuticals Corp.'s price-to-earnings ratio?
Phio Pharmaceuticals Corp. (:PHIO) has a price-to-earnings ratio of -0.34 and price/earnings-to-growth ratio is -0.02.
